PPA
AKCA

Parametric Portfolio Associates’s Akcea Therapeutics Inc AKCA Stock Holding History

Parametric Portfolio Associates’s Portfolio AKCA Stock Details AKCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-44,776
Closed -$812K – 4073
2020
Q3 		$812K Buy
44,776
+33,339
+292% +$473K ﹤0.01% 3044
2020
Q2 		$157K Sell
11,437
-2,752
-19% -$42.5K ﹤0.01% 3694
2020
Q1 		$203K Buy
14,189
+2,867
+25% +$47.1K ﹤0.01% 3548
2019
Q4 		$192K Buy
+11,322
New +$211K ﹤0.01% 3758
2019
Q3 		– Sell
-11,955
Closed -$280K – 4035
2019
Q2 		$280K Buy
11,955
+4,339
+57% +$107K ﹤0.01% 3609
2019
Q1 		$216K Sell
7,616
-1,083
-12% -$31.5K ﹤0.01% 3693
2018
Q4 		$262K Buy
+8,699
New +$244K ﹤0.01% 3568

Parametric Portfolio Associates's AKCA Position: Q4 2020 in Review

Parametric Portfolio Associates sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 44,776 shares — an estimated $812K sold.

Parametric Portfolio Associates first reported a position in AKCA in Q4 2018 and held it in 7 quarters. The position peaked at $812K in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

  • Parametric Portfolio Associates reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
  • Parametric Portfolio Associates sold 44,776 Akcea Therapeutics Inc shares in Q4 2020, an estimated $812K.
  • Parametric Portfolio Associates first reported a position in Akcea Therapeutics Inc in Q4 2018 and held it in 7 quarters.
  • Parametric Portfolio Associates's Akcea Therapeutics Inc position peaked at $812K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Parametric Portfolio Associates's 13F filing for Q4 2020, filed 12 Feb 2021.